Tags

Type your tag names separated by a space and hit enter

Oral contraception and breast pathology.
Acta Eur Fertil. 1981 Jun; 12(2):141-63.AE

Abstract

After a rapid examination of the international literature concerning human, animal, histological and epidemiological experimental data, the Authors state that the use of oral contraceptives considerably reduces the risk of benign disease of the breast. This risk reduction seems to be connected to the presence of progestin in this type of contraception. The Authors then expound the data regarding a group of patients (3527), who came to the center for the diagosis and prevention of cancer of the breast at the S. Martino hospital of Genoa during the years 1977-1980. The results of the study are comparable to those found in international literature, in that they confirm the protective effect of hormonal contraception on benign pathology of the breast. Finally we have shown the data of the retrospective and prospective studies conducted up till now on the effects of hormonal contraception on malignant breast pathology. In conclusion we have shown which lines of study should be taken in order to clarify once and for all the links existing between estroprogestins and cancer of the breast.

Authors

No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng ita

PubMed ID

6794288

Citation

Ragni, N, et al. "Oral Contraception and Breast Pathology." Acta Europaea Fertilitatis, vol. 12, no. 2, 1981, pp. 141-63.
Ragni N, Boccardo E, Viglino S, et al. Oral contraception and breast pathology. Acta Eur Fertil. 1981;12(2):141-63.
Ragni, N., Boccardo, E., Viglino, S., & Larosa, E. (1981). Oral contraception and breast pathology. Acta Europaea Fertilitatis, 12(2), 141-63.
Ragni N, et al. Oral Contraception and Breast Pathology. Acta Eur Fertil. 1981;12(2):141-63. PubMed PMID: 6794288.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Oral contraception and breast pathology. AU - Ragni,N, AU - Boccardo,E, AU - Viglino,S, AU - Larosa,E, PY - 1981/6/1/pubmed PY - 1981/6/1/medline PY - 1981/6/1/entrez KW - Age Factors KW - Animals, Laboratory KW - Biology KW - Breast Cancer KW - Cancer KW - Clinical Research KW - Contraception KW - Contraceptive Methods--side effects KW - Diseases KW - Family Planning KW - Literature Review KW - Mammary Gland Effects KW - Neoplasms KW - Oral Contraceptives--side effects KW - Physiology KW - Research Methodology SP - 141 EP - 63 JF - Acta Europaea fertilitatis JO - Acta Eur. Fertil. VL - 12 IS - 2 N2 - After a rapid examination of the international literature concerning human, animal, histological and epidemiological experimental data, the Authors state that the use of oral contraceptives considerably reduces the risk of benign disease of the breast. This risk reduction seems to be connected to the presence of progestin in this type of contraception. The Authors then expound the data regarding a group of patients (3527), who came to the center for the diagosis and prevention of cancer of the breast at the S. Martino hospital of Genoa during the years 1977-1980. The results of the study are comparable to those found in international literature, in that they confirm the protective effect of hormonal contraception on benign pathology of the breast. Finally we have shown the data of the retrospective and prospective studies conducted up till now on the effects of hormonal contraception on malignant breast pathology. In conclusion we have shown which lines of study should be taken in order to clarify once and for all the links existing between estroprogestins and cancer of the breast. SN - 0587-2421 UR - https://www.unboundmedicine.com/medline/citation/6794288/Oral_contraception_and_breast_pathology_ L2 - https://medlineplus.gov/breastcancer.html DB - PRIME DP - Unbound Medicine ER -